2026 Annual Public Meeting

2026 Annual Public Meeting of the Board of Directors

July 21, 2026
2:30pm (eastern)

Each year, the Reagan-Udall Foundation for the FDA’s Board of Directors conducts an annual public meeting to highlight our activities in support of the U.S. Food and Drug Administration. The meeting provides an opportunity for engagement among the Foundation’s Board of Directors, FDA, and external stakeholders, including patients and consumers, regulated industry, health care providers, academics, and others dedicated to improving America’s health.

Our 2026 meeting will feature insights and Agency priorities from Acting FDA Commissioner Kyle Diamantas, FDA Chief Scientist Steven Kozlowski, and Acting FDA Chief of Staff Lowell Zeta.

The meeting will also include updates on the Foundation’s impact with Board Chair Adrian F. Hernandez, MD, MHS; Board Directors David C. Fajgenbaum, MD, MBA, Phuong Khanh (PK) Morrow, MD, and Pietro Antonio Tataranni, MD; and CEO Susan C. Winckler, RPh, Esq.

Review the Slides